210 related articles for article (PubMed ID: 19536445)
61. Patterns of psychiatric hospital service use in Finland: a national register study of hospital discharges in the early 1990s.
Korkeila JA; Lehtinen V; Tuori T; Helenius H
Soc Psychiatry Psychiatr Epidemiol; 1998 May; 33(5):218-23. PubMed ID: 9604671
[TBL] [Abstract][Full Text] [Related]
62. Predictors of Length of Stay in an Inpatient Psychiatric Unit of a General Hospital in Perugia, Italy.
Pauselli L; Verdolini N; Bernardini F; Compton MT; Quartesan R
Psychiatr Q; 2017 Mar; 88(1):129-140. PubMed ID: 27167133
[TBL] [Abstract][Full Text] [Related]
63. [Hospitalization trends of neuropsychiatric disorders in a middle-income country].
Pérez-Esparza R; Kobayashi-Romero LF; Fonseca-Perezamador A; Velásquez-Pérez L
Rev Med Inst Mex Seguro Soc; 2019 Dec; 57(6):340-347. PubMed ID: 33001609
[TBL] [Abstract][Full Text] [Related]
64. Antipsychotic monotherapy and adjuvant psychotropic therapies in schizophrenia patients: effect on time to readmission.
Valevski A; Gilat Y; Olfson M; Benaroya-Milshtein N; Weizman A
Int Clin Psychopharmacol; 2012 May; 27(3):159-64. PubMed ID: 22466059
[TBL] [Abstract][Full Text] [Related]
65. Optimizing outcomes in schizophrenia: long-acting depots and long-term treatment.
Morrissette DA; Stahl SM
CNS Spectr; 2012 Nov; 17 Suppl 1():10-21. PubMed ID: 23462201
[TBL] [Abstract][Full Text] [Related]
66. Challenges in the design and conduct of controlled clinical effectiveness trials in schizophrenia.
Rosenheck RA; Krystal JH; Lew R; Barnett PG; Thwin SS; Fiore L; Valley D; Huang GD; Neal C; Vertrees JE; Liang MH;
Clin Trials; 2011 Apr; 8(2):196-204. PubMed ID: 21270143
[TBL] [Abstract][Full Text] [Related]
67. Patterns of antipsychotic utilization in a tertiary care psychiatric institution.
Procyshyn RM; Thompson B
Pharmacopsychiatry; 2004 Jan; 37(1):12-7. PubMed ID: 14750043
[TBL] [Abstract][Full Text] [Related]
68. Sex, ethnicity, and antipsychotic medication use in patients with psychosis.
Arnold LM; Strakowski SM; Schwiers ML; Amicone J; Fleck DE; Corey KB; Farrow JE
Schizophr Res; 2004 Feb; 66(2-3):169-75. PubMed ID: 15061250
[TBL] [Abstract][Full Text] [Related]
69. Clozapine for treatment-resistant schizophrenia: National Institute of Clinical Excellence (NICE) guidance in the real world.
Mortimer AM; Singh P; Shepherd CJ; Puthiryackal J
Clin Schizophr Relat Psychoses; 2010 Apr; 4(1):49-55. PubMed ID: 20643629
[TBL] [Abstract][Full Text] [Related]
70. [Psychopharmocotherapy of schizophrenia in forensic and general psychiatry].
Stompe T; Schanda H
Neuropsychiatr; 2011; 25(2):75-84. PubMed ID: 21672506
[TBL] [Abstract][Full Text] [Related]
71. The revolving door phenomenon in severe psychiatric disorders: A systematic review.
Fonseca Barbosa J; Gama Marques J
Int J Soc Psychiatry; 2023 Aug; 69(5):1075-1089. PubMed ID: 37209104
[TBL] [Abstract][Full Text] [Related]
72. Antipsychotic prescription filling in patients with schizophrenia or schizoaffective disorder.
Reutfors J; Brandt L; Stephansson O; Kieler H; Andersen M; Bodén R
J Clin Psychopharmacol; 2013 Dec; 33(6):759-65. PubMed ID: 24126686
[TBL] [Abstract][Full Text] [Related]
73. Olanzapine therapy in treatment-resistant psychotic mood disorders: a long-term follow-up study.
Narendran R; Young CM; Valenti AM; Pristach CA; Pato MT; Grace JJ
J Clin Psychiatry; 2001 Jul; 62(7):509-16. PubMed ID: 11488360
[TBL] [Abstract][Full Text] [Related]
74. Impact of length of stay for first psychiatric admissions on the ratio of readmissions in subsequent years in a large Brazilian catchment area.
Barros RE; Marques JM; Santos JL; Zuardi AW; Del-Ben CM
Soc Psychiatry Psychiatr Epidemiol; 2016 Apr; 51(4):575-87. PubMed ID: 26801498
[TBL] [Abstract][Full Text] [Related]
75. Locked in and Growing Old: The Psychiatric, Forensic, and Cognitive Correlates of 30 Years of Psychiatric Hospitalization.
Hives F; Karyadi KA; Nitch S; Kinney D
Am J Geriatr Psychiatry; 2018 Feb; 26(2):188-197. PubMed ID: 29122420
[TBL] [Abstract][Full Text] [Related]
76. Naturalistic pharmacotherapy of acute episodes of schizophrenic disorders in comparison to treatment guidelines.
Stein M; Dietrich DE; Agelink MW; Becker W; Chrysanthou C; Driessen M; Kruse G; Machleidt W; Reker T; Schneider U; Schulze Mönking H; Emrich HM; Arolt V; Rothermundt M
Pharmacopsychiatry; 2012 Jul; 45(5):189-95. PubMed ID: 22456956
[TBL] [Abstract][Full Text] [Related]
77. Predictors of relapse in the year after hospital discharge among patients with schizophrenia.
Schennach R; Obermeier M; Meyer S; Jäger M; Schmauss M; Laux G; Pfeiffer H; Naber D; Schmidt LG; Gaebel W; Klosterkötter J; Heuser I; Maier W; Lemke MR; Rüther E; Klingberg S; Gastpar M; Seemüller F; Möller HJ; Riedel M
Psychiatr Serv; 2012 Jan; 63(1):87-90. PubMed ID: 22227766
[TBL] [Abstract][Full Text] [Related]
78. Choosing antipsychotic maintenance therapy--a naturalistic study.
Tavcar R; Dernovsek MZ; Zvan V
Pharmacopsychiatry; 2000 Mar; 33(2):66-71. PubMed ID: 10761822
[TBL] [Abstract][Full Text] [Related]
79. Comparison of treatment discontinuation and hospitalization among nonadherent patients initiating depot or oral typical antipsychotic medications.
Novick D; Haro JM; Bertsch J; Anand H; Jemiai N; Haddad PM
Int Clin Psychopharmacol; 2012 Sep; 27(5):275-82. PubMed ID: 22699789
[TBL] [Abstract][Full Text] [Related]
80. Clinical predictors of acute risperidone response in schizophrenia, schizoaffective disorder, and psychotic mood disorders.
Keck PE; Wilson DR; Strakowski SM; McElroy SL; Kizer DL; Balistreri TM; Holtman HM; DePriest M
J Clin Psychiatry; 1995 Oct; 56(10):466-70. PubMed ID: 7559373
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
